Field walking tests are commonly employed to evaluate exercise capacity, assess prognosis
and evaluate treatment response in chronic respiratory diseases. In recent years, there has …

At least 5% of sarcoidosis patients die from their disease, usually from advanced pulmonary
sarcoidosis. The three major problems encountered in advanced pulmonary sarcoidosis are …

The aim of this case–control study was to investigate the prevalence of exercise intolerance,
muscle weakness and fatigue in sarcoidosis patients. Additionally, we evaluated whether …

Materials and Methods All consecutive patients with confirmed diagnosis of chronic
pulmonary diseases were included from January 2013 to June 2014 in tertiary care institute …

Background Sarcoidosis patients frequently experience fatigue, exercise intolerance and
muscle weakness, resulting in reduced quality of life (QoL). Scientific studies on the benefits …

Background: Real-world data on the effects of a multicomponent pulmonary rehabilitation
(PR) for patients with sarcoidosis are scarce. Objective: To describe characteristics of …

Introduction Sarcoidosis associated pulmonary hypertension (SAPH) is a leading contributor
to sarcoidosis-related mortality. The 6-min walk test (6MWT) is widely used in assessment of …

Background Physical exercise aids glycemic control and the prevention of diabetes-related
complications. However, exercise beyond an individual's pulmonary functional capacity may …

六分钟步行试验是目前已被公认的评价受试者心肺功能研究方法之一. 它操作简便, 安全,
可重复性高, 费用低廉. 由于它在慢性肺疾病患者病死率中具有很高的预测价值 …

BACKGROUND: Pulmonary hypertension (PH) occurs in many patients with interstitial lung
disease, including sarcoidosis. We explored the frequency, clinical characteristics and …